Celgene Corp. took its traditional place as the opening act for the J.P. Morgan Healthcare Conference in San Francisco last week and despite unveiling a deal to buy Impact Biomedicines, there were rumblings from analysts that the company, which has been the darling of Wall Street for a number of years, is losing its golden touch.
Yet less than two months ago, Celgene was being feted by the great and good of the biopharmaceutical world at the 13th Annual Scrip Awards at The Hilton on Park Lane, London where more than 500 guests saw the firm win the Pharma Company of the Year Award, sponsored by PPD
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?